SMLR vs. ZYXI, AXGN, EDAP, OM, ELMD, FONR, VANI, HYPR, CUTR, and POCI
Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Zynex (ZYXI), AxoGen (AXGN), Edap Tms (EDAP), Outset Medical (OM), Electromed (ELMD), FONAR (FONR), Vivani Medical (VANI), Hyperfine (HYPR), Cutera (CUTR), and Precision Optics (POCI). These companies are all part of the "electromedical equipment" industry.
Zynex (NASDAQ:ZYXI) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings, risk and community ranking.
In the previous week, Semler Scientific had 9 more articles in the media than Zynex. MarketBeat recorded 10 mentions for Semler Scientific and 1 mentions for Zynex. Semler Scientific's average media sentiment score of 1.44 beat Zynex's score of 0.52 indicating that Zynex is being referred to more favorably in the media.
Semler Scientific has a net margin of 32.92% compared to Semler Scientific's net margin of 4.33%. Zynex's return on equity of 30.36% beat Semler Scientific's return on equity.
Zynex has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500.
Zynex presently has a consensus target price of $18.00, suggesting a potential upside of 77.34%. Given Semler Scientific's higher probable upside, analysts clearly believe Zynex is more favorable than Semler Scientific.
Zynex received 21 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 51.16% of users gave Zynex an outperform vote while only 50.00% of users gave Semler Scientific an outperform vote.
29.7% of Zynex shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 52.1% of Zynex shares are owned by company insiders. Comparatively, 13.0% of Semler Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Semler Scientific has lower revenue, but higher earnings than Zynex. Semler Scientific is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.
Summary
Semler Scientific beats Zynex on 11 of the 19 factors compared between the two stocks.
Get Semler Scientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Semler Scientific Competitors List
Related Companies and Tools
